Abstract:624 Objectives: Idiopathic Parkinson’s disease (IPD) and atypical parkinsonian syndromes may have similar symptoms at the early disease stage. Positron emission tomography (PET) with 18F-FDG was shown to be be able to assess early neuronal dysfunction of taupathies. In the past decades, machine learning on metabolic patterns has been established for the differential diagnosis of parkinsonism [1]. Recent advancement of deep learning has brought record-breaking performance in many applications. This study examined whether this artificial intelligence tool is of value in an early differential diagnosis of parkinsonism. Methods: 257 patients with clinical features suspected for parkinsonism were subjected to an 18F-FDG PET imaging. After the imaging, these patients were followed up at least 1 year by blinded movement disorders specialists before a final clinical diagnosis of IPD (n=136), multiple system atrophy (MSA, n=91), and progressive supranuclear palsy (PSP, n=30) were made. To enable the fast establishment of deep neural network with limited computational power, a tensor factorization method [2] was employed to compress 3D brain imaging data to 2D images (supplemental figure). Then, A 4-layer convolutional neural network (CNN) was established to differentiate IPD, MSA and PSP based on the tensor-factorized 2D images. To enhance the performance, the CNN network was pretrained with a large database of brain FDG PET images. To this end, 1077 subjects of 41 various neurological diseases were included. Five fold cross validation was applied for the training and test of the pretrained CNN on the 257 parkinsonian patients. The classification CNN was implemented using python on Google9s TensorFlow platform and accelerated using NVIDIA Titan X graphics card. Results: After 85 iterations, all the folds for the test of the 2D CNN on tensor factorized images converges. The training took 3204 seconds. The test network has achieved 98.9% sensitivity, 90.0% specificity, 98.4% PPV and 95.0% NPV for the differentiation of PD, 98.8% sensitivity, 82.5% specificity, 96.1% PPV and 96.0% NPV for the classification of MSA and 87.1% sensitivity, 97.8% specificity, 96.1% PPV and 94.1% NPV for the classification of PSP. Conclusions: The preliminary test of deep learning on tensor factorized FDG PET images has demonstrated its ability to reach a cpmparable accuracy of state-of-the-art. Enlarging the database and further optimizing the deep neural network may enhance its potential in an early differential diagnosis of Parkinsonism. Physiological interpretation of the performance of the deep learning method needs to be investigated further.. Blind test on a separate group of parkinsonian patients is currently ongoing for in-depth assessment of the deep learning Methods: References: [1] Tang et al. Lancet Neuro 2010 [2] Li et al. MICCAI 2017 Research support: The study was supported by grants (No.81771483, No. 81671239, No. 81401135 and No. 81361120393) from the National Natural Science Foundation of China.

Deep learning-based classification improves clinical interpretation of [18F]florzolotau PET

Improved Interpretation of 18F-Florzolotau PET in Progressive Supranuclear Palsy Using a Normalization-Free Deep-Learning Classifier.

International Consensus on the Use of Tau PET Imaging Agent 18F-Flortaucipir in Alzheimer's Disease.

Deep Learning on 18F-FDG PET Imaging for Differential Diagnosis of Parkinsonian Syndromes

A deep learning framework for 18 F-FDG PET imaging diagnosis in pediatric patients with temporal lobe epilepsy

18F-Florzolotau PET Imaging Captures the Distribution Patterns and Regional Vulnerability of Tau Pathology in Progressive Supranuclear Palsy

18F‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies

Pet Image Resolution Uniformity Improvements Using Deep Learning

AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning

Visual Reading for [18f]florzolotau Tau PET Scans in Progressive Supranuclear Palsy

Contrastive Learning for Prediction of Alzheimer's Disease Using Brain 18F-FDG PET

Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy

A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET

Deep Learning-Based Classification and Voxel-Based Visualization of Frontotemporal Dementia and Alzheimer’s Disease

Classification of amyloid PET images using novel features for early diagnosis of Alzheimer's disease and mild cognitive impairment conversion

MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI

Deep learning-based binary classification of beta-amyloid plaques using 18 F florapronol PET

TauAD: MRI-free Tau Anomaly Detection in PET Imaging via Conditioned Diffusion Models

Deep Learning-Based Prediction of PET Amyloid Status Using Multi-Contrast MRI

Computer-Aided Classification Framework of Parkinsonian Disorders Using 11C-CFT PET Imaging